• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定和验证一种适用于 C 亚型感染人群的横断面 HIV 发病率估计的多检测算法。

Identification and validation of a multi-assay algorithm for cross-sectional HIV incidence estimation in populations with subtype C infection.

机构信息

Laboratory of Immunoregulation, NIAID, NIH, Baltimore, MD, USA.

Division of Infectious Diseases, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD, USA.

出版信息

J Int AIDS Soc. 2018 Feb;21(2). doi: 10.1002/jia2.25082.

DOI:10.1002/jia2.25082
PMID:29489059
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5829581/
Abstract

INTRODUCTION

Cross-sectional methods can be used to estimate HIV incidence for surveillance and prevention studies. We evaluated assays and multi-assay algorithms (MAAs) for incidence estimation in subtype C settings.

METHODS

We analysed samples from individuals with subtype C infection with known duration of infection (2442 samples from 278 adults; 0.1 to 9.9 years after seroconversion). MAAs included 1-4 of the following assays: Limiting Antigen Avidity assay (LAg-Avidity), BioRad-Avidity assay, CD4 cell count and viral load (VL). We evaluated 23,400 MAAs with different assays and assay cutoffs. We identified the MAA with the largest mean window period, where the upper 95% confidence interval (CI) of the shadow was <1 year. This MAA was compared to the LAg-Avidity and BioRad-Avidity assays alone, a widely used LAg algorithm (LAg-Avidity <1.5 OD-n + VL >1000 copies/mL), and two MAAs previously optimized for subtype B settings. We compared these cross-sectional incidence estimates to observed incidence in an independent longitudinal cohort.

RESULTS

The optimal MAA was LAg-Avidity <2.8 OD-n  +  BioRad-Avidity <95% + VL >400 copies/mL. This MAA had a mean window period of 248 days (95% CI: 218, 284), a shadow of 306 days (95% CI: 255, 359), and provided the most accurate and precise incidence estimate for the independent cohort. The widely used LAg algorithm had a shorter mean window period (142 days, 95% CI: 118, 167), a longer shadow (410 days, 95% CI; 318, 491), and a less accurate and precise incidence estimate for the independent cohort.

CONCLUSIONS

An optimal MAA was identified for cross-sectional HIV incidence in subtype C settings. The performance of this MAA is superior to a testing algorithm currently used for global HIV surveillance.

摘要

简介

横断面研究方法可用于监测和预防研究中估计 HIV 发病率。我们评估了适用于 C 型亚型的估计发病率的检测方法和多检测算法(MAAs)。

方法

我们分析了已知感染持续时间(278 名成年人中有 2442 名样本;从血清转换后 0.1 至 9.9 年)的 C 型亚型感染个体的样本。MAAs 包括以下 1-4 种检测方法:有限抗原亲和力检测(LAg-Avidity)、BioRad-Avidity 检测、CD4 细胞计数和病毒载量(VL)。我们评估了 23400 个具有不同检测方法和检测截止值的 MAAs。我们确定了 MAA 的最大平均窗口期,即上限 95%置信区间(CI)<1 年。该 MAA 与 LAg-Avidity 和 BioRad-Avidity 检测单独比较,与广泛使用的 LAg 算法(LAg-Avidity <1.5 OD-n + VL >1000 拷贝/ml)和两种针对 B 型亚型优化的 MAA 进行比较。我们将这些横断面发病率估计与独立纵向队列中的观察到的发病率进行了比较。

结果

最佳 MAA 是 LAg-Avidity <2.8 OD-n + BioRad-Avidity <95% + VL >400 拷贝/ml。该 MAA 的平均窗口期为 248 天(95%CI:218,284),阴影期为 306 天(95%CI:255,359),为独立队列提供了最准确和最精确的发病率估计。广泛使用的 LAg 算法的平均窗口期较短(142 天,95%CI:118,167),阴影期较长(410 天,95%CI:318,491),对独立队列的发病率估计准确性和精确性较低。

结论

在 C 型亚型环境中确定了最佳的 MAA 用于横断面 HIV 发病率估计。该 MAA 的性能优于当前用于全球 HIV 监测的检测算法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86c5/5829581/e87666a83c7d/JIA2-21-e25082-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86c5/5829581/1dd2999b6387/JIA2-21-e25082-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86c5/5829581/e87666a83c7d/JIA2-21-e25082-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86c5/5829581/1dd2999b6387/JIA2-21-e25082-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86c5/5829581/e87666a83c7d/JIA2-21-e25082-g002.jpg

相似文献

1
Identification and validation of a multi-assay algorithm for cross-sectional HIV incidence estimation in populations with subtype C infection.鉴定和验证一种适用于 C 亚型感染人群的横断面 HIV 发病率估计的多检测算法。
J Int AIDS Soc. 2018 Feb;21(2). doi: 10.1002/jia2.25082.
2
Performance of a limiting-antigen avidity enzyme immunoassay for cross-sectional estimation of HIV incidence in the United States.一种用于美国HIV发病率横断面估计的限量抗原亲和力酶免疫测定法的性能
PLoS One. 2013 Dec 27;8(12):e82772. doi: 10.1371/journal.pone.0082772. eCollection 2013.
3
Evaluation of multi-assay algorithms for cross-sectional HIV incidence estimation in settings with universal antiretroviral treatment.在普遍开展抗逆转录病毒治疗的环境中,评估用于横断面 HIV 发病率估计的多分析算法。
BMC Infect Dis. 2022 Nov 11;22(1):838. doi: 10.1186/s12879-022-07850-0.
4
Validation of population-level HIV-1 incidence estimation by cross-sectional incidence assays in the HPTN 071 (PopART) trial.通过 HPTN 071(PopART)试验中的横断面发病率检测对人群 HIV-1 发病率估计进行验证。
J Int AIDS Soc. 2021 Dec;24(12):e25830. doi: 10.1002/jia2.25830.
5
A comparison of two measures of HIV diversity in multi-assay algorithms for HIV incidence estimation.用于估计HIV发病率的多检测算法中两种HIV多样性测量方法的比较。
PLoS One. 2014 Jun 26;9(6):e101043. doi: 10.1371/journal.pone.0101043. eCollection 2014.
6
Evaluation of multi-assay algorithms for identifying individuals with recent HIV infection: HPTN 071 (PopART).评估用于识别近期 HIV 感染者的多分析算法:HPTN 071(PopART)。
PLoS One. 2021 Dec 17;16(12):e0258644. doi: 10.1371/journal.pone.0258644. eCollection 2021.
7
HIV diversity as a biomarker for HIV incidence estimation: including a high-resolution melting diversity assay in a multiassay algorithm.HIV 多样性作为 HIV 感染率估计的生物标志物:在多测定法算法中包含高分辨率熔解多样性测定法。
J Clin Microbiol. 2014 Jan;52(1):115-21. doi: 10.1128/JCM.02040-13. Epub 2013 Oct 23.
8
Field Validation of Limiting-Antigen Avidity Enzyme Immunoassay to Estimate HIV-1 Incidence in Cross-Sectional Survey in Swaziland.在斯威士兰横断面调查中,用于估计HIV-1发病率的限量抗原亲和力酶免疫测定的现场验证
AIDS Res Hum Retroviruses. 2019 Oct;35(10):896-905. doi: 10.1089/AID.2018.0284. Epub 2019 Aug 15.
9
Development of methods for cross-sectional HIV incidence estimation in a large, community randomized trial.在一项大型社区随机试验中开发用于横断面 HIV 发病率估计的方法。
PLoS One. 2013 Nov 13;8(11):e78818. doi: 10.1371/journal.pone.0078818. eCollection 2013.
10
Validation of the Limiting Antigen Avidity Assay to Estimate Level and Trends in HIV Incidence in an A/D Epidemic in Rakai, Uganda.乌干达拉凯地区A/D型艾滋病流行中用于估计HIV发病率水平及趋势的有限抗原亲和力检测法的验证
AIDS Res Hum Retroviruses. 2019 Apr;35(4):364-367. doi: 10.1089/AID.2018.0207. Epub 2019 Jan 29.

引用本文的文献

1
An enhanced cross-sectional HIV incidence estimator that incorporates prior HIV test results.一种纳入既往HIV检测结果的改进型横断面HIV发病率估计方法。
Stat Med. 2024 Jul 30;43(17):3125-3139. doi: 10.1002/sim.10112. Epub 2024 May 27.
2
Study design approaches for future active-controlled HIV prevention trials.未来活性对照HIV预防试验的研究设计方法
Stat Commun Infect Dis. 2024 Jan 22;15(1):20230002. doi: 10.1515/scid-2023-0002. eCollection 2024 Jan.
3
Development of a multiassay algorithm (MAA) to identify recent HIV infection in newly diagnosed individuals in Indonesia.

本文引用的文献

1
Short Communication: Heightened HIV Antibody Responses in Postpartum Women as Exemplified by Recent Infection Assays: Implications for Incidence Estimates.简短通讯:以近期感染检测为例,产后女性中HIV抗体反应增强:对发病率估计的影响
AIDS Res Hum Retroviruses. 2017 Sep;33(9):902-904. doi: 10.1089/AID.2016.0319. Epub 2017 May 24.
2
Comparison of cross-sectional HIV incidence assay results from dried blood spots and plasma.干血斑与血浆的横断面HIV发病率检测结果比较
PLoS One. 2017 Feb 23;12(2):e0172283. doi: 10.1371/journal.pone.0172283. eCollection 2017.
3
The effect of a conditional cash transfer on HIV incidence in young women in rural South Africa (HPTN 068): a phase 3, randomised controlled trial.
开发一种多检测算法(MAA)以识别印度尼西亚新诊断个体中的近期HIV感染情况。
iScience. 2023 Sep 21;26(10):107986. doi: 10.1016/j.isci.2023.107986. eCollection 2023 Oct 20.
4
Evaluation of multi-assay algorithms for cross-sectional HIV incidence estimation in settings with universal antiretroviral treatment.在普遍开展抗逆转录病毒治疗的环境中,评估用于横断面 HIV 发病率估计的多分析算法。
BMC Infect Dis. 2022 Nov 11;22(1):838. doi: 10.1186/s12879-022-07850-0.
5
Recent HIV Infection: Diagnosis and Public Health Implications.近期HIV感染:诊断及对公共卫生的影响
Diagnostics (Basel). 2022 Nov 1;12(11):2657. doi: 10.3390/diagnostics12112657.
6
Antiretroviral Drug Resistance in HIV Sequences From People Who Inject Drugs and Men Who Have Sex With Men Across 21 Cities in India.印度21个城市中注射吸毒者和男男性行为者的艾滋病毒序列中的抗逆转录病毒药物耐药性
Open Forum Infect Dis. 2022 Sep 17;9(10):ofac481. doi: 10.1093/ofid/ofac481. eCollection 2022 Oct.
7
A systematic review of limiting antigen avidity enzyme immunoassay for detection of recent HIV-1 infection to expand supported applications.一项关于限制抗原亲和力酶免疫测定法检测近期HIV-1感染以扩大支持应用的系统评价。
J Virus Erad. 2022 Sep 7;8(3):100085. doi: 10.1016/j.jve.2022.100085. eCollection 2022 Sep.
8
Use of HIV Recency Assays for HIV Incidence Estimation and Other Surveillance Use Cases: Systematic Review.使用 HIV 近期感染检测方法进行 HIV 发病率估计和其他监测应用案例:系统评价。
JMIR Public Health Surveill. 2022 Mar 11;8(3):e34410. doi: 10.2196/34410.
9
Statistical considerations for cross-sectional HIV incidence estimation based on recency test.基于近期检测的横断面 HIV 发病率估计的统计考虑因素。
Stat Med. 2022 Apr 15;41(8):1446-1461. doi: 10.1002/sim.9296. Epub 2022 Jan 4.
10
Evaluation of multi-assay algorithms for identifying individuals with recent HIV infection: HPTN 071 (PopART).评估用于识别近期 HIV 感染者的多分析算法:HPTN 071(PopART)。
PLoS One. 2021 Dec 17;16(12):e0258644. doi: 10.1371/journal.pone.0258644. eCollection 2021.
南非农村地区年轻女性中条件性现金转移对艾滋病毒发病率的影响(HPTN 068):一项 3 期、随机对照试验。
Lancet Glob Health. 2016 Dec;4(12):e978-e988. doi: 10.1016/S2214-109X(16)30253-4. Epub 2016 Nov 1.
4
Estimation of HIV incidence in two Brazilian municipalities, 2013.2013年巴西两个城市的艾滋病毒发病率估计
Rev Saude Publica. 2016 Sep 1;50:55. doi: 10.1590/S1518-8787.2016050006310.
5
Viral load criteria and threshold optimization to improve HIV incidence assay characteristics.优化病毒载量标准和阈值以改善HIV发病率检测特征。
AIDS. 2016 Sep 24;30(15):2361-71. doi: 10.1097/QAD.0000000000001209.
6
Community viral load, antiretroviral therapy coverage, and HIV incidence in India: a cross-sectional, comparative study.印度的社区病毒载量、抗逆转录病毒疗法覆盖率及艾滋病毒发病率:一项横断面比较研究。
Lancet HIV. 2016 Apr;3(4):e183-90. doi: 10.1016/S2352-3018(16)00019-9. Epub 2016 Mar 11.
7
Closer to 90-90-90. The cascade of care after 10 years of ART scale-up in rural Malawi: a population study.更接近90-90-90目标。马拉维农村地区扩大抗逆转录病毒治疗10年后的连续护理:一项人群研究。
J Int AIDS Soc. 2016 Feb 15;19(1):20673. doi: 10.7448/IAS.19.1.20673. eCollection 2016.
8
Sample size methods for estimating HIV incidence from cross-sectional surveys.通过横断面调查估计艾滋病毒发病率的样本量方法。
Biometrics. 2015 Dec;71(4):1121-9. doi: 10.1111/biom.12336. Epub 2015 Aug 24.
9
A Comparison of South African National HIV Incidence Estimates: A Critical Appraisal of Different Methods.南非全国艾滋病毒发病率估计值的比较:对不同方法的批判性评估
PLoS One. 2015 Jul 31;10(7):e0133255. doi: 10.1371/journal.pone.0133255. eCollection 2015.
10
Recalibration of the limiting antigen avidity EIA to determine mean duration of recent infection in divergent HIV-1 subtypes.重新校准限制性抗原亲和力酶免疫测定法以确定不同HIV-1亚型近期感染的平均持续时间。
PLoS One. 2015 Feb 24;10(2):e0114947. doi: 10.1371/journal.pone.0114947. eCollection 2015.